Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

Mesoblast (MESO) announced that it has entered into the Medicaid National Drug Rebate Agreement, NDRA, with the U.S. Centers for Medicare & ...